Novartis Japan Revenue Nearly Hit Bottom, FY2016 Sales Down 3.7%: New Chief

July 25, 2017
Novartis Pharma President Kazunari Tsunaba Meets Press Japan sales of Novartis appear to have nearly touched bottom in FY2016 as its major products with no generic competition grew year on year across the board, but the company still has a...read more